Cepheid, MedImmune, COMBACTE Ink Bacterial Dx Collaboration | GenomeWeb

NEW YORK (GenomeWeb) – Cepheid today announced a collaboration with MedImmune and the COMBACTE consortium to develop rapid tests for the diagnosis of Staphylococcus aureus and Pseudomonas aeruginosa.

The tests will look for signs of infection in respiratory secretions of mechanically ventilated patients, to help identify patients for clinical trials evaluating the use of biologics to prevent ventilator associated pneumonia (VAP) in intensive care unit patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.